Brief: Erytech Announces Receipt Of Nasdaq Notice
Oct 13 (Reuters) - Erytech Pharma SA ERYP.PA :
* ERYTECH ANNOUNCES RECEIPT OF NASDAQ NOTICE
* ERYTECH PHARMA SA - RECEIVED NOTIFICATION FROM NASDAQ
DATED OCT
7, 2022, THAT CO NO LONGER SATISFIES NASDAQ LISTING RULE
5450(A)(1)
Source text for Eikon: ID:nGNX32wnTV
Further company coverage: ERYP.PA
((reuters.briefs@thomsonreuters.com;))
Recent news on Phaxiam Therapeutics SA
See all newsBrief: Phaxiam Therapeutics Announces The Suspension Of Trading In Its Shares Until Delisting
Brief: Phaxiam Therapeutics Announces Judicial Liquidation And Delisting
Brief: Phaxiam Therapeutics Says Postponement Of The Offer Review Hearing
Brief: Phaxiam Therapeutics Announces Launch Of Process To Find Buyers In Context Of Its Receivership Procedure
Brief: Phaxiam Therapeutics Says Commercial Court Of Lyon To Open Judicial Receivership Procedure